stars 1 stars 2 stars 3

View neuronics's top competitors like Aural Analytics, BrainCo_Tech, and Cerevel Therapeutics.

Neurocrine Biosciences
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines *in collaboration with AbbVie
San Diego, California, US
Public
$2.4B Revenue
http://www.neurocrine.com
2.5K Employees
NBIX Ticker
NeuroFlow
NeuroFlow helps risk-bearing healthcare organizations improve outcomes and cost of care in complex populations by surfacing and supporting behavioral health needs that typically go undetected and under-addressed. Across payors, providers, and the federal government, NeuroFlow’s scalable technology and analytics capabilities empower organizations with actionable intelligence from real-time data collection and risk stratification, enabling them to manage populations in a financially sustainable way. Powered by deep expertise in whole-person care, NeuroFlow offers a path to risk predictability and proactive care that helps overcome the systemic challenges in today’s healthcare ecosystem.
Philadelphia, Pennsylvania, US
Private
$21M Revenue
http://www.neuroflow.com
180 Employees
Cerevel Therapeutics
Cerevel is now part of AbbVie. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.
North Chicago, Illinois, US
Public
$63M Revenue
http://www.cerevel.com
37 Employees
CERE Ticker
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users